Publication:
Red cell antibodies in thalassemia hemoglobinopathy patients.

dc.contributor.authorP. Tardtongen_US
dc.contributor.authorP. Ratanasirivanichen_US
dc.contributor.authorP. Chiewsilpen_US
dc.contributor.authorP. Hathiraten_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-06-14T09:06:49Z
dc.date.available2018-06-14T09:06:49Z
dc.date.issued1988-01-01en_US
dc.description.abstractOne hundred sixty-four previously transfused patients with T/H disease received one to 136 transfusions with an average of 14.65. Immunization to red blood cell occurred in 14 patients (8.5%). Among these, 11 patients had alloantibody, one patient had autoimmune antibody, and two patients had both alloantibody and autoimmune antibody. The naturally occurring antibody (anti-Leb) was observed in pretransfused blood samples of two patients (1.2%). Most red cell immunization seemed to occur in the early period of blood transfusion.en_US
dc.identifier.citationBirth defects original article series. Vol.23, No.5 B (1988), 287-289en_US
dc.identifier.issn05476844en_US
dc.identifier.other2-s2.0-0023704470en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/15523
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0023704470&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectMedicineen_US
dc.titleRed cell antibodies in thalassemia hemoglobinopathy patients.en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0023704470&origin=inwarden_US

Files

Collections